- call +1-201-465-4211
- email sales@mrinsights.biz
HIV-AIDS is a chronic disease caused by the human immunodeficiency virus (HIV). HIV virus damages human immune system, which results weakness of immune system and loss ability to fight with organism that causes disease.
Scope of the Report:
This report studies the HIV/AIDS Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the HIV/AIDS Testing market by product type and applications/end industries.
HIV-AIDS most often spread through unprotected sex with HIV infected person. In addition, HIV-AIDS can also be spread from infected mother to child during pregnancy, infected blood and sharing needles with someone who has HIV-AIDS. Some of the symptoms of HIV include slight fever, swollen glands, muscle aches, headaches and fatigue.
HIV-AIDS has no cure but there are treatments which help to reduce AIDS deaths. HIV-AIDS can be treated by nucleoside/ nucleotide reverse transcriptase inhibitor, integrase inhibitor, HIV-1 protease inhibitor, non-nucleoside reverse transcriptase inhibitor, pharmacokinetic enhancer and entry inhibitor. Some of the drugs for HIV -AIDS treatment include atripla, epzicom, prezista, truvada, kaletra, isentress, reyataz and viread.
The global HIV/AIDS Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of HIV/AIDS Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Lonza
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Kits and Reagents
Instruments
Others
Market Segment by Applications, can be divided into
Hospitals
Private Diagnostics Laboratories
Academic and Research Institutes
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 HIV/AIDS Testing Market Overview
1.1 Product Overview and Scope of HIV/AIDS Testing
1.2 Classification of HIV/AIDS Testing by Types
1.2.1 Global HIV/AIDS Testing Revenue Comparison by Types (2017-2023)
1.2.2 Global HIV/AIDS Testing Revenue Market Share by Types in 2017
1.2.3 Kits and Reagents
1.2.4 Instruments
1.2.5 Others
1.3 Global HIV/AIDS Testing Market by Application
1.3.1 Global HIV/AIDS Testing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Private Diagnostics Laboratories
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Global HIV/AIDS Testing Market by Regions
1.4.1 Global HIV/AIDS Testing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) HIV/AIDS Testing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) HIV/AIDS Testing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) HIV/AIDS Testing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) HIV/AIDS Testing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) HIV/AIDS Testing Status and Prospect (2013-2023)
1.5 Global Market Size of HIV/AIDS Testing (2013-2023)
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Business Overview
2.1.2 HIV/AIDS Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott HIV/AIDS Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 Affymetrix
2.2.1 Business Overview
2.2.2 HIV/AIDS Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Affymetrix HIV/AIDS Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Beckman Coulter/Danaher
2.3.1 Business Overview
2.3.2 HIV/AIDS Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Beckman Coulter/Danaher HIV/AIDS Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Becton Dickinson
2.4.1 Business Overview
2.4.2 HIV/AIDS Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Becton Dickinson HIV/AIDS Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 bioMerieux
2.5.1 Business Overview
2.5.2 HIV/AIDS Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 bioMerieux HIV/AIDS Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bio-Rad
2.6.1 Business Overview
2.6.2 HIV/AIDS Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bio-Rad HIV/AIDS Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Cepheid
2.7.1 Business Overview
2.7.2 HIV/AIDS Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Cepheid HIV/AIDS Testing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Diamedix
2.8.1 Business Overview
2.8.2 HIV/AIDS Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Diamedix HIV/AIDS Testing Revenue, Gross Margin and Market Share (2016-2017)
2.9 DiaSorin
2.9.1 Business Overview
2.9.2 HIV/AIDS Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 DiaSorin HIV/AIDS Testing Revenue, Gross Margin and Market Share (2016-2017)
2.10 Eiken Chemical
2.10.1 Business Overview
2.10.2 HIV/AIDS Testing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Eiken Chemical HIV/AIDS Testing Revenue, Gross Margin and Market Share (2016-2017)
2.11 Elitech Group
2.11.1 Business Overview
2.11.2 HIV/AIDS Testing Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Elitech Group HIV/AIDS Testing Revenue, Gross Margin and Market Share (2016-2017)
2.12 Enzo Biochem
2.12.1 Business Overview
2.12.2 HIV/AIDS Testing Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Enzo Biochem HIV/AIDS Testing Revenue, Gross Margin and Market Share (2016-2017)
2.13 Fujirebio
2.13.1 Business Overview
2.13.2 HIV/AIDS Testing Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Fujirebio HIV/AIDS Testing Revenue, Gross Margin and Market Share (2016-2017)
2.14 Lonza
2.14.1 Business Overview
2.14.2 HIV/AIDS Testing Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Lonza HIV/AIDS Testing Revenue, Gross Margin and Market Share (2016-2017)
2.15 Roche
2.15.1 Business Overview
2.15.2 HIV/AIDS Testing Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Roche HIV/AIDS Testing Revenue, Gross Margin and Market Share (2016-2017)
2.16 Scienion
2.16.1 Business Overview
2.16.2 HIV/AIDS Testing Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Scienion HIV/AIDS Testing Revenue, Gross Margin and Market Share (2016-2017)
2.17 Sequenom
2.17.1 Business Overview
2.17.2 HIV/AIDS Testing Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Sequenom HIV/AIDS Testing Revenue, Gross Margin and Market Share (2016-2017)
2.18 SeraCare
2.18.1 Business Overview
2.18.2 HIV/AIDS Testing Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 SeraCare HIV/AIDS Testing Revenue, Gross Margin and Market Share (2016-2017)
2.19 Siemens
2.19.1 Business Overview
2.19.2 HIV/AIDS Testing Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Siemens HIV/AIDS Testing Revenue, Gross Margin and Market Share (2016-2017)
2.20 Takara Bio
2.20.1 Business Overview
2.20.2 HIV/AIDS Testing Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Takara Bio HIV/AIDS Testing Revenue, Gross Margin and Market Share (2016-2017)
3 Global HIV/AIDS Testing Market Competition, by Players
3.1 Global HIV/AIDS Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 HIV/AIDS Testing Players Market Share
3.2.2 Top 10 HIV/AIDS Testing Players Market Share
3.3 Market Competition Trend
4 Global HIV/AIDS Testing Market Size by Regions
4.1 Global HIV/AIDS Testing Revenue and Market Share by Regions
4.2 North America HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
4.3 Europe HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
4.5 South America HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
5 North America HIV/AIDS Testing Revenue by Countries
5.1 North America HIV/AIDS Testing Revenue by Countries (2013-2018)
5.2 USA HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
5.3 Canada HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
6 Europe HIV/AIDS Testing Revenue by Countries
6.1 Europe HIV/AIDS Testing Revenue by Countries (2013-2018)
6.2 Germany HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
6.3 UK HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
6.4 France HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
6.5 Russia HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
6.6 Italy HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific HIV/AIDS Testing Revenue by Countries
7.1 Asia-Pacific HIV/AIDS Testing Revenue by Countries (2013-2018)
7.2 China HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
7.3 Japan HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
7.4 Korea HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
7.5 India HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
8 South America HIV/AIDS Testing Revenue by Countries
8.1 South America HIV/AIDS Testing Revenue by Countries (2013-2018)
8.2 Brazil HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue HIV/AIDS Testing by Countries
9.1 Middle East and Africa HIV/AIDS Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
9.3 UAE HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa HIV/AIDS Testing Revenue and Growth Rate (2013-2018)
10 Global HIV/AIDS Testing Market Segment by Type
10.1 Global HIV/AIDS Testing Revenue and Market Share by Type (2013-2018)
10.2 Global HIV/AIDS Testing Market Forecast by Type (2018-2023)
10.3 Kits and Reagents Revenue Growth Rate (2013-2023)
10.4 Instruments Revenue Growth Rate (2013-2023)
10.5 Others Revenue Growth Rate (2013-2023)
11 Global HIV/AIDS Testing Market Segment by Application
11.1 Global HIV/AIDS Testing Revenue Market Share by Application (2013-2018)
11.2 HIV/AIDS Testing Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Private Diagnostics Laboratories Revenue Growth (2013-2018)
11.5 Academic and Research Institutes Revenue Growth (2013-2018)
11.6 Others Revenue Growth (2013-2018)
12 Global HIV/AIDS Testing Market Size Forecast (2018-2023)
12.1 Global HIV/AIDS Testing Market Size Forecast (2018-2023)
12.2 Global HIV/AIDS Testing Market Forecast by Regions (2018-2023)
12.3 North America HIV/AIDS Testing Revenue Market Forecast (2018-2023)
12.4 Europe HIV/AIDS Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific HIV/AIDS Testing Revenue Market Forecast (2018-2023)
12.6 South America HIV/AIDS Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa HIV/AIDS Testing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure HIV/AIDS Testing Picture
Table Product Specifications of HIV/AIDS Testing
Table Global HIV/AIDS Testing and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
